Drug Patent Watch

MAY 5, 2024

This chart shows the pharmaceutical companies with the most patents in Hong Kong.

Pharmaceutical Companies 91

Pharmaceutical Companies Pharmaceutical Companies 91

Pharmacy Times

MAY 5, 2024

With these findings contributing to the understanding of neighborhood-level asthma risks, the authors note next steps can involve identifying and addressing disparities.

59

59

Drug Patent Watch

MAY 5, 2024

Annual Drug Patent Expirations for DUAVEE Duavee is a drug marketed by Wyeth Pharms and is included in one NDA. It is available from two suppliers.

59

59

PharmaTech

MAY 5, 2024

Webinar Date/Time: Tue, Jun 4, 2024 9:00 AM EDT

Packaging 52

Packaging 52

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Express Pharma

MAY 5, 2024

According to the company’s statement, all EIRs are in place for their USFDA facilities After an inspection carried out by the US Food and Drug Administration ( USFDA), Alembic Pharmaceuticals has received its Establishment Inspection Report (EIR) for its oncology (injectable and oral solid) formulation facility. Located at Panelav, the inspection was carried out from February 28 to March 8, 2024.

52

52

RX Note

MAY 5, 2024

Introduction The 7 Habits of Highly Effective People , first published in 1989, is a business and self-help book by Stephen R. Covey. A sequel, titled The 8th Habit: From Effectiveness to Greatness , followed in 2004. Deep Roots for Lasting Solutions Significant problems we face cannot be solved with the same level of thinking that created them. In all of life, there are sequential stages of growth and development.

52

52

Express Pharma

MAY 5, 2024

Phase 1 trial shows 90 per cent recurrence-free survival and 90 per cent complete response in patients with high-risk and intermediate-risk non-muscle-invasive bladder cancer, respectively Janssen-Cilag International NV, a Johnson & Johnson company, recently updated results from an open-label, multicentre, multi-cohort Phase 1 study of the safety and efficacy of TAR-210, an intravesical targeted releasing system designed to provide sustained, local release of erdafitinib into the bladder, i

Labelling 104

Labelling 104

Pharmacy Joe

MAY 5, 2024

In this episode, I’ll discuss the problem with hypo-osmolar solutions in neurological patients. Episode 919: The problem with hypo-osmolar solutions in neurological patients Subscribe on iTunes , Android , or Stitcher The administration of hypo-osmolar IV solutions causes an increase in water into the brain. This is because an intact blood-brain barrier is permeable to water but not electrolytes.

Hospitals 52

Hospitals Inpatient 52

FDA Law Blog: Biosimilars

MAY 5, 2024

By Larry K. Houck — The Associated Press reported on Tuesday following confirmation by five anonymous individuals with knowledge that the Drug Enforcement Administration (“DEA”) is moving to reschedule marijuana from schedule I to the less stringently controlled schedule III. US poised to ease restrictions on marijuana in historic shift, but it’ll remain controlled substance (Apr. 30, 2024).

Controlled Substances 95

Controlled Substances Chemotherapy Dosage Labelling 95